Immediate Impact
45 standout
Citing Papers
The interplay between cytokines, inflammation, and antioxidants: mechanistic insights and therapeutic potentials of various antioxidants and anti-cytokine compounds
2024 Standout
New clinical trial design in precision medicine: discovery, development and direction
2024 Standout
Works of Franck Drouet being referenced
A phase II randomized trial of pembrolizumab versus cetuximab, concomitant with radiotherapy (RT) in locally advanced (LA) squamous cell carcinoma of the head and neck (SCCHN): First results of the GORTEC 2015-01 “PembroRad” trial.
2018
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Franck Drouet | 69 | 40 | 101 | 52 | 10 | 162 | |
| Ewa Wasilewska-Teśluk | 117 | 19 | 98 | 22 | 14 | 191 | |
| Lokesh Viswanath | 46 | 27 | 59 | 31 | 14 | 113 | |
| Xu-Shan Sun | 72 | 33 | 114 | 36 | 11 | 172 | |
| Anders Berglund | 33 | 21 | 51 | 31 | 16 | 146 | |
| Michiel de Maaker | 18 | 27 | 61 | 43 | 9 | 172 | |
| N. Lee | 89 | 30 | 126 | 57 | 8 | 230 | |
| Qinqin Liu | 38 | 83 | 93 | 102 | 14 | 204 | |
| Olivier Ballivy | 90 | 36 | 66 | 73 | 14 | 191 | |
| Birgit Lindeløv | 47 | 55 | 43 | 32 | 10 | 147 | |
| Maria Lucia Iacovino | 69 | 51 | 127 | 45 | 13 | 215 |
All Works
Loading papers...